Alembic Pharma in JV agreement with Orbicular
To develop and commercialise dermatology products for global markets
Author
Cadila Pharma initiates awareness campaigns to observe ‘World TB Day’
Multi-city patient awareness programmes, free diagnosis, rallies, radio, street play and film activity has been planned to raise…
MSF welcomes Ministry of Commerce clarification on Compulsory Licensing
Warns US pressure on India will continue
The Ministry of Commerce recently clarified that media reports claiming that the…
Apeiron Biologics and Columbia University sign exclusive license agreement
To develop and commercialise active cellular immunotherapies under licensed patents, which cover inhibition of Cbl-b in T cells…
EY Entrepreneur of The Year Awards announced
Vinita and Nilesh Gupta of Lupin and Samir Mehta of Torrent Pharma receive the award
Vinita Gupta, Chief Executive Officer and…
CphI India Pre-Connect Congress held in Mumbai
Experts discuss the current trends in pharma industry at the event
The CphI India Pre-Connect Congress recently held in Mumbai,…
Cipla ready to launch low-dose Efavirenz 400 mg
Studies found that the reduced dose of 400 mg Efavirenz was non-inferior to the standard dose of 600 mg Efavirenz dose
Clinical trials for new diabetes drugs urgently needed In India: ISCR
On the occasion of World Diabetes Day (November 14), the Indian Society for Clinical Research (ISCR), an association of clinical…
Experts address impact of M&A in pharma and promoting API manufacturing in India
M&A report recommendations focused on pricing, production and availability, R&D and social consequences
In order to…